Advertisement
Screener

LEXARIA BIOSCIENCE CORP. (LEXX) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

LEXARIA BIOSCIENCE CORP. Financing Cash Flow

LEXARIA BIOSCIENCE CORP. (LEXX) reported Financing Cash Flow of $6.52 million for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-13

  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for the quarter ending 2026-05-31 was $0.00, a 100.00% decline year-over-year.
  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for the quarter ending 2026-02-28 was $3.04M, a 25873.16% increase year-over-year.
  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for the quarter ending 2025-11-30 was $3.47M, a 20.05% decline year-over-year.
  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for the quarter ending 2025-08-31 was $0.00.
  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for fiscal 2025 was $6.05M, a 41.39% decline from fiscal 2024.
  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for fiscal 2024 was $10.32M, a 548.86% increase from fiscal 2023.
  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for fiscal 2023 was $1.59M.
  • LEXARIA BIOSCIENCE CORP. net cash provided by (used in) financing activities for fiscal 2022 was -$44.60K, a 100.33% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 6 month as first filedNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 10 monthNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 12 month as first filed
2026-05-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13
$3.04M
derived: sum of 2 quarters · filed 2026-07-13
$6.52M
10-Q · filed 2026-07-13
$6.52M
derived: sum of 4 quarters · filed 2026-07-13
2026-02-28$3.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13
$6.52M
10-Q · filed 2026-04-13
$6.52M
derived: sum of 3 quarters · filed 2026-04-13
$8.21M
derived: sum of 4 quarters · filed 2026-07-13
2025-11-30$3.47M
10-Q · filed 2026-01-13
$3.47M
derived: sum of 2 quarters · filed 2026-01-13
$5.16M
derived: sum of 3 quarters · filed 2026-07-13
$5.17M
derived: sum of 4 quarters · filed 2026-07-13
2025-08-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28
$1.69M
derived: sum of 2 quarters · filed 2026-07-13
$1.70M
derived: sum of 3 quarters · filed 2026-07-13
$6.05M
10-K · filed 2025-11-28
2025-05-31$1.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13
$1.70M
derived: sum of 2 quarters · filed 2026-07-13
$6.05M
10-Q · filed 2026-07-13
$6.05M
derived: sum of 4 quarters · filed 2026-07-13
2025-02-28$11.72K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13
$4.36M
10-Q · filed 2026-04-13
$4.36M
derived: sum of 3 quarters · filed 2026-04-13
$9.40M
derived: sum of 4 quarters · filed 2026-04-13
2024-11-30$4.35M
10-Q · filed 2026-01-13
$4.35M
derived: sum of 2 quarters · filed 2026-01-13
$9.39M
derived: sum of 3 quarters · filed 2026-01-13
$12.84M
derived: sum of 4 quarters · filed 2026-01-13
2024-08-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28
$5.04M
derived: sum of 2 quarters · filed 2025-11-28
$8.50M
derived: sum of 3 quarters · filed 2025-11-28
$10.32M
10-K · filed 2025-11-28
2024-05-31$5.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-07-14
$8.50M
derived: sum of 2 quarters · filed 2025-07-14
$10.32M
10-Q · filed 2025-07-14
$10.19M
derived: sum of 4 quarters · filed 2025-07-14
2024-02-29$3.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-04-14
$5.27M
10-Q · filed 2025-04-14
$5.15M
derived: sum of 3 quarters · filed 2025-04-14
$6.86M
derived: sum of 4 quarters · filed 2025-04-14
2023-11-30$1.82M
10-Q · filed 2025-01-10
$1.70M
derived: sum of 2 quarters · filed 2025-01-10
$3.41M
derived: sum of 3 quarters · filed 2025-01-10
$3.41M
derived: sum of 4 quarters · filed 2025-01-10
2023-08-31-$121.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20
$1.59M
derived: sum of 2 quarters · filed 2024-07-12
$1.59M
derived: sum of 3 quarters · filed 2024-07-12
$1.59M
10-K · filed 2023-11-20
2023-05-31$1.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-07-12
$1.71M
derived: sum of 2 quarters · filed 2024-07-12
$1.71M
10-Q · filed 2024-07-12
$1.70M
derived: sum of 4 quarters · filed 2024-07-12
2023-02-28$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-04-09
$0.00
10-Q · filed 2024-04-09
-$11.21K
derived: sum of 3 quarters · filed 2024-04-09
-$22.41K
derived: sum of 4 quarters · filed 2024-04-09
2022-11-30$0.00
10-Q · filed 2024-01-12
-$11.20K
10-Q · filed 2023-01-17
-$11.21K
derived: sum of 2 quarters · filed 2024-01-12
-$22.41K
derived: sum of 3 quarters · filed 2024-01-12
-$33.61K
derived: sum of 4 quarters · filed 2024-01-12
2022-08-31-$11.21K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-20
-$22.41K
derived: sum of 2 quarters · filed 2023-11-20
-$33.61K
derived: sum of 3 quarters · filed 2023-11-20
-$44.60K
10-K · filed 2023-11-20
2022-05-31-$11.20K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-07-14
-$22.41K
derived: sum of 2 quarters · filed 2023-07-14
-$33.40K
10-Q · filed 2023-07-14
$3.97M
derived: sum of 4 quarters · filed 2023-07-14
2022-02-28-$11.20K
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-04-14
-$22.19K
10-Q · filed 2023-04-14
$22.19K
10-Q · filed 2022-04-11
$3.98M
derived: sum of 3 quarters · filed 2023-04-14
$3.97M
derived: sum of 4 quarters · filed 2023-04-14
2021-11-30-$10.99K
10-Q/A · filed 2023-01-18
$3.99M
derived: sum of 2 quarters · filed 2023-01-18
$3.98M
derived: sum of 3 quarters · filed 2023-01-18
$13.42M
derived: sum of 4 quarters · filed 2023-01-18
2021-08-31$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28
$3.99M
derived: sum of 2 quarters · filed 2022-11-28
$13.43M
derived: sum of 3 quarters · filed 2022-11-28
$13.42M
10-K · filed 2022-11-28
2021-05-31-$10.99K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14
$9.42M
derived: sum of 2 quarters · filed 2022-07-14
$9.42M
10-Q · filed 2022-07-14
$9.45M
10-Q · filed 2021-07-15
$9.33M
derived: sum of 4 quarters · filed 2022-07-14
2021-02-28$9.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11
$9.43M
10-Q · filed 2022-04-11
$9.45M
10-Q · filed 2021-04-14
$9.34M
derived: sum of 3 quarters · filed 2022-04-11
$11.25M
derived: sum of 4 quarters · filed 2022-04-11
2020-11-30-$8.77K
10-Q · filed 2022-01-14
-$97.92K
derived: sum of 2 quarters · filed 2022-01-14
$1.82M
derived: sum of 3 quarters · filed 2022-01-14
$1.94M
derived: sum of 4 quarters · filed 2022-01-14
2020-08-31-$89.15K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29
$1.83M
derived: sum of 2 quarters · filed 2021-11-29
$1.95M
derived: sum of 3 quarters · filed 2021-11-29
$2.65M
10-K · filed 2021-11-29
$2.70M
10-K · filed 2020-10-15
2020-05-31$1.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15
$2.04M
derived: sum of 2 quarters · filed 2021-07-15
$2.74M
10-Q · filed 2021-07-15
$2.80M
derived: sum of 4 quarters · filed 2021-07-15
2020-02-29$120.32K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14
$827.02K
10-Q · filed 2021-04-14
$886.02K
derived: sum of 3 quarters · filed 2021-04-14
$2.13M
derived: sum of 4 quarters · filed 2021-04-14
2019-11-30$706.70K
10-Q · filed 2021-01-14
$765.70K
derived: sum of 2 quarters · filed 2021-01-14
$2.01M
derived: sum of 3 quarters · filed 2021-01-14
$2.39M
derived: sum of 4 quarters · filed 2021-01-14
2019-08-31$59.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15
$1.30M
derived: sum of 2 quarters · filed 2020-10-15
$1.68M
derived: sum of 3 quarters · filed 2020-10-15
$3.33M
10-K · filed 2020-10-15
2019-05-31$1.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29
$1.62M
derived: sum of 2 quarters · filed 2020-06-29
$3.27M
10-Q · filed 2020-06-29
$3.80M
derived: sum of 4 quarters · filed 2020-06-29
2019-02-28$381.30K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03
$2.03M
10-Q · filed 2020-04-03
$2.56M
derived: sum of 3 quarters · filed 2020-04-03
$2.89M
derived: sum of 4 quarters · filed 2020-04-03
2018-11-30$1.65M
10-Q · filed 2020-01-09
$2.18M
derived: sum of 2 quarters · filed 2020-01-09
$2.51M
derived: sum of 3 quarters · filed 2020-01-09
$3.23M
derived: sum of 4 quarters · filed 2020-01-09
2018-08-31$527.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14
$859.63K
derived: sum of 2 quarters · filed 2019-11-14
$1.58M
derived: sum of 3 quarters · filed 2019-11-14
$1.87M
10-K · filed 2019-11-14
2018-05-31$332.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08
$1.06M
derived: sum of 2 quarters · filed 2019-07-08
$1.34M
10-Q · filed 2019-07-08
$1.44M
derived: sum of 4 quarters · filed 2019-07-08
2018-02-28$725.19K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15
$1.01M
10-Q · filed 2019-04-15
$1.11M
derived: sum of 3 quarters · filed 2019-04-15
$3.97M
derived: sum of 4 quarters · filed 2019-04-15
2017-11-30$282.40K
10-Q · filed 2019-01-11
$380.10K
derived: sum of 2 quarters · filed 2019-01-11
$3.25M
derived: sum of 3 quarters · filed 2019-01-11
$4.13M
derived: sum of 4 quarters · filed 2019-01-11
2017-08-31$97.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14
$2.97M
derived: sum of 2 quarters · filed 2018-11-14
$3.85M
derived: sum of 3 quarters · filed 2018-11-14
$4.00M
10-K · filed 2018-11-14
2017-05-31$2.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13
$3.75M
derived: sum of 2 quarters · filed 2018-07-13
$3.90M
10-Q · filed 2018-07-13
$4.22M
derived: sum of 4 quarters · filed 2018-11-14
2017-02-28$883.49K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12
$1.03M
10-Q · filed 2018-04-12
$1.35M
derived: sum of 3 quarters · filed 2018-11-14
2016-11-30$145.51K
10-Q · filed 2018-01-12
$467.32K
derived: sum of 2 quarters · filed 2018-11-14
2016-08-31$321.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14
$514.29K
10-K · filed 2018-11-14
2016-05-31$192.48K
10-Q · filed 2017-07-14
2016-02-29$86.98K
10-Q · filed 2017-04-14
2015-11-30$36.00K
10-Q · filed 2017-01-13
$40.90K
derived: sum of 2 quarters · filed 2017-01-13
2015-08-31$4.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29
$373.25K
10-K · filed 2016-11-29
2015-05-31$368.36K
10-Q · filed 2016-07-13
2015-02-28-$98.74K
10-Q · filed 2016-04-13
2014-11-30-$98.74K
10-Q · filed 2016-01-08
-$570.95K
derived: sum of 2 quarters · filed 2016-01-08
2014-08-31-$472.21K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27
$1.23M
10-KT · filed 2014-12-09
$1.23M
10-K · filed 2015-11-27
2014-07-31-$98.82K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$952.60K
derived: sum of 2 quarters · filed 2014-11-14
$1.03M
10-Q · filed 2014-11-14
2014-05-31$1.70M
10-Q · filed 2015-07-14
2014-04-30$1.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12
$1.13M
10-Q · filed 2014-06-12
2014-02-28$0.00
10-Q · filed 2015-04-14
2014-01-31$80.00K
10-Q · filed 2014-03-12
2013-11-30$0.00
10-Q · filed 2015-01-14
2013-10-31-$30.03K
derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09
-$107.20K
derived: sum of 2 quarters · filed 2014-12-09
-$198.43K
derived: sum of 3 quarters · filed 2014-12-09
-$365.36K
10-KT · filed 2014-12-09
2013-08-31-$348.00K
10-KT · filed 2014-12-09
2013-07-31-$77.17K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
-$168.41K
derived: sum of 2 quarters · filed 2014-11-14
-$335.33K
10-Q · filed 2014-11-14
-$347.83K
derived: sum of 4 quarters · filed 2014-11-14
2013-04-30-$91.23K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12
-$258.16K
10-Q · filed 2014-06-12
-$270.65K
derived: sum of 3 quarters · filed 2014-06-12
-$220.65K
derived: sum of 4 quarters · filed 2014-06-12
2013-01-31-$166.93K
10-Q · filed 2014-03-12
-$179.42K
derived: sum of 2 quarters · filed 2014-03-12
-$129.42K
derived: sum of 3 quarters · filed 2014-03-12
-$79.42K
derived: sum of 4 quarters · filed 2014-03-12
2012-10-31-$12.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24
$37.50K
derived: sum of 2 quarters · filed 2014-01-24
$87.50K
derived: sum of 3 quarters · filed 2014-01-24
$287.50K
10-K · filed 2014-01-24
2012-07-31$50.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10
$100.00K
derived: sum of 2 quarters · filed 2013-09-10
$300.00K
10-Q · filed 2013-09-10
$265.37K
derived: sum of 4 quarters · filed 2013-09-10
2012-04-30$50.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-12
$250.00K
10-Q · filed 2013-06-12
$215.37K
derived: sum of 3 quarters · filed 2013-06-12
$611.08K
derived: sum of 4 quarters · filed 2013-06-12
2012-01-31$200.00K
10-Q · filed 2013-03-13
$165.37K
derived: sum of 2 quarters · filed 2013-03-13
$561.08K
derived: sum of 3 quarters · filed 2013-03-13
$531.40K
derived: sum of 4 quarters · filed 2013-03-13
2011-10-31-$34.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29
$361.07K
derived: sum of 2 quarters · filed 2013-01-29
$331.40K
derived: sum of 3 quarters · filed 2013-01-29
$861.00K
10-K · filed 2013-01-29
2011-07-31$395.71K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-12
$366.04K
derived: sum of 2 quarters · filed 2012-09-12
$895.64K
10-Q · filed 2012-09-12
$985.64K
derived: sum of 4 quarters · filed 2012-09-12
2011-04-30-$29.67K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-07
$499.93K
10-Q · filed 2012-06-07
$589.93K
derived: sum of 3 quarters · filed 2012-06-07
2011-01-31$529.60K
10-Q · filed 2012-03-13
$619.60K
derived: sum of 2 quarters · filed 2012-03-13
2010-10-31$90.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30
$348.40K
10-K · filed 2012-01-30
2010-07-31$258.40K
10-Q · filed 2011-09-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Rallybio Corp (RLYB)United States$0.089B
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30